|
1
|
Alexander C and Rietschel ET: Bacterial
lipopolysaccharides and innate immunity. J Endotoxin Res.
7:167–202. 2001.PubMed/NCBI
|
|
2
|
Unger RE, Peters K, Sartoris A, Freese C
and Kirkpatrick CJ: Human endothelial cell-based assay for
endotoxin as sensitive as the conventional Limulus Amebocyte Lysate
assay. Biomaterials. 35:3180–3187. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Beutler B and Rietschel ET: Innate immune
sensing and its roots: The story of endotoxin. Nat Rev Immunol.
3:169–176. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bone RC, Balk RA, Cerra FB, Dellinger RP,
Fein AM, Knaus WA, Schein RM and Sibbald WJ; The ACCP/SCCM
Consensus Conference Committee. American College of Chest
Physicians/Society of Critical Care Medicine: Definitions for
sepsis and organ failure and guidelines for the use of innovative
therapies in sepsis. Chest. 101:1644–1655. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamamoto M, Sato S, Hemmi H, Sanjo H,
Uematsu S, Kaisho T, Hoshino K, Takeuchi O, Kobayashi M, Fujita T,
et al: Essential role for TIRAP in activation of the signalling
cascade shared by TLR2 and TLR4. Nature. 420:324–329. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li X and Qin J: Modulation of
Toll-interleukin 1 receptor mediated signaling. J Mol Med (Berl).
83:258–266. 2005. View Article : Google Scholar
|
|
7
|
Miyake K: Endotoxin recognition molecules,
Toll-like receptor 4-MD-2. Semin Immunol. 16:11–16. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Medzhitov R, Preston-Hurlburt P and
Janeway CA Jr: A human homologue of the Drosophila Toll protein
signals activation of adaptive immunity. Nature. 388:394–397. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moynagh PN: TLR signalling and activation
of IRFs: Revisiting old friends from the NF-kappaB pathway. Trends
Immunol. 26:469–476. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huo M, Cui X, Xue J, Chi G, Gao R, Deng X,
Guan S, Wei J, Soromou LW, Feng H, et al: Anti-inflammatory effects
of linalool in RAW264.7 macrophages and lipopolysaccharide-induced
lung injury model. J Surg Res. 180:e47–e54. 2013. View Article : Google Scholar
|
|
11
|
Craig R, Larkin A, Mingo AM, Thuerauf DJ,
Andrews C, McDonough PM and Glembotski CC: p38 MAPK and NF-kappaB
collaborate to induce interleukin-6 gene expression and release.
Evidence for a cytoprotective autocrine signaling pathway in a
cardiac myocyte model system. J Biol Chem. 275:23814–23824. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sakaguchi S, Yamaguchi T, Nomura T and Ono
M: Regulatory T cells and immune tolerance. Cell. 133:775–787.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen W, Jin W, Hardegen N, Lei KJ, Li L,
Marinos N, McGrady G and Wahl SM: Conversion of peripheral
CD4+CD25− naive T cells to
CD4+CD25+ regulatory T cells by TGF-beta
induction of transcription factor Foxp3. J Exp Med. 198:1875–1886.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shevach EM: Mechanisms of
foxp3+ T regulatory cell-mediated suppression. Immunity.
30:636–645. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Klayman DL: Qinghaosu (artemisinin): An
antimalarial drug from China. Science. 228:1049–1055. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo J, Xu H and Chen K: Systematic review
of compound danshen dropping pill: a chinese patent medicine for
acute myocardial infarction. Evid Based Complement Alternat Med.
2013:8080762013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu T, Wang DX, Zhang W, Liao XQ, Guan X,
Bo H, Sun JY, Huang NW, He J, Zhang YK, et al: Andrographolide
protects against LPS-induced acute lung injury by inactivation of
NF-κB. PLoS One. 8:e564072013. View Article : Google Scholar
|
|
18
|
Yu PJ, Li JR, Zhu ZG, Kong HY, Jin H,
Zhang JY, Tian YX, Li ZH, Wu XY, Zhang JJ, et al: Praeruptorin D
and E attenuate lipopolysaccharide/hydrochloric acid induced acute
lung injury in mice. Eur J Pharmacol. 710:39–48. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li T, Zhang J, Feng J, Li Q, Wu L, Ye Q,
Sun J, Lin Y, Zhang M, Huang R, et al: Resveratrol reduces acute
lung injury in a LPS induced sepsis mouse model via activation of
Sirt1. Mol Med Rep. 7:1889–1895. 2013.PubMed/NCBI
|
|
20
|
Shi Y, Zhang B, Chen XJ, Xu DQ, Wang YX,
Dong HY, Ma SR, Sun RH, Hui YP and Li ZC: Osthole protects
lipopolysaccharide-induced acute lung injury in mice by preventing
downregulation of angiotensin-converting enzyme 2. Eur J Pharm Sci.
48:819–824. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu WB, Li DP, Zhang GL, Sun L and Zhang
NS: Study progress of the pharmacological activity of forsythoside
A. Chin Anim Husbandry Vet Med. 38:236–238. 2011.In Chinese.
|
|
22
|
Lu S, Chen SN, Guan JY and Shen H: Effects
of forsythoside on cell functions of raw264.7 stimulated by LPS.
Zhongguo Nongxue Tongbao. 28:58–62. 2012.In Chinese.
|
|
23
|
Liu H, Sidiropoulos P, Song G, Pagliari
LJ, Birrer MJ, Stein B, Anrather J and Pope RM: TNF-alpha gene
expression in macrophages: Regulation by NF-kappa B is independent
of c-Jun or C/EBP beta. J Immunol. 164:4277–4285. 2000. View Article : Google Scholar
|
|
24
|
Perumal Samy R and Gopalakrishnakone P:
Therapeutic potential of plants as anti-microbials for drug
discovery. Evid Based Complement Alternat Med. 7:283–294. 2010.
View Article : Google Scholar :
|
|
25
|
Hu JY, Lei L, Yu Y and Deng WL: Studies on
the anti-inflammatory and antipyretic effect of forsythia.
Pharmocol Clin Chin Mater Med. 23:51–52. 2007.
|
|
26
|
Qin Z, Xu J and Zhang LJ: Studies on the
anti-bacteria effect of fructus forsythia and folium forsythia in
vitro. Food Eng. 2:49–52. 2013.
|
|
27
|
Shao Y, Wang X, Cai SX, Gao W and Wu X:
Hemodynamic effect of polymyxin B sulfate on rats with endotoxemia.
Chongqing Univ (Natur Sci Ed). 25:84–86. 2002.
|
|
28
|
Mitaka C and Tomita M: Polymyxin
B-immobilized fiber column hemoperfusion therapy for septic shock.
Shock. 36:332–338. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Figueiredo RT, Bittencourt VCB, Lopes LCL,
Sassaki G and Barreto-Bergter E: Toll-like receptors (TLR2 and
TLR4) recognize polysaccharides of Pseudallescheria boydii cell
wall. Carbohydr Res. 356:260–264. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu YC, Yeh WC and Ohashi PS: LPS/TLR4
signal transduction pathway. Cytokine. 42:145–151. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee JK, Kim SY, Kim YS, Lee WH, Hwang DH
and Lee JY: Suppression of the TRIF-dependent signaling pathway of
Toll-like receptors by luteolin. Biochem Pharmacol. 77:1391–1400.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Słotwiński R, Słotwińska S, Kędziora S and
Bałan BJ: Innate immunity signaling pathways: Links between
immunonutrition and responses to sepsis. Arch Immunol Ther Exp
(Warsz). 59:139–150. 2011. View Article : Google Scholar
|
|
33
|
Bradley JR: TNF-mediated inflammatory
disease. J Pathol. 214:149–160. 2008. View Article : Google Scholar
|
|
34
|
Wu Y and Zhou BP:
TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and
invasion. Br J Cancer. 102:639–644. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Caramalho I, Lopes-Carvalho T, Ostler D,
Zelenay S, Haury M and Demengeot J: Regulatory T cells selectively
express toll-like receptors and are activated by
lipopolysaccharide. J Exp Med. 197:403–411. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kosmaczewska A, Ciszak L, Potoczek S and
Frydecka I: The significance of Treg cells in defective tumor
immunity. Arch Immunol Ther Exp (Warsz). 56:181–191. 2008.
View Article : Google Scholar
|
|
37
|
Nakamura K, Kitani A and Strober W: Cell
contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T
cells is mediated by cell surface-bound transforming growth factor
beta. J Exp Med. 194:629–644. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fontenot JD, Gavin MA and Rudensky AY:
Foxp3 programs the development and function of
CD4+CD25+ regulatory T cells. Nat Immunol.
4:330–336. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lal G, Zhang N, van der Touw W, Ding Y, Ju
W, Bottinger EP, Reid SP, Levy DE and Bromberg JS: Epigenetic
regulation of Foxp3 expression in regulatory T cells by DNA
methylation. J Immunol. 182:259–273. 2009. View Article : Google Scholar
|
|
40
|
Fontenot JD and Rudensky AY: A well
adapted regulatory contrivance: Regulatory T cell development and
the forkhead family transcription factor Foxp3. Nat Immunol.
6:331–337. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wildin RS and Freitas A: IPEX and FOXP3:
Clinical and research perspectives. J Autoimmun. 25(Suppl): 56–62.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Murai M, Turovskaya O, Kim G, Madan R,
Karp CL, Cheroutre H and Kronenberg M: Interleukin 10 acts on
regulatory T cells to maintain expression of the transcription
factor Foxp3 and suppressive function in mice with colitis. Nat
Immunol. 10:1178–1184. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kawamoto K, Pahuja A, Hering BJ and
Bansal-Pakala P: Transforming growth factor beta 1 (TGF-beta1) and
rapamycin synergize to effectively suppress human T cell responses
via upregulation of FoxP3+ Tregs. Transpl Immunol.
23:28–33. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yan B and Da WM:
CD4+CD25+ regulatory T cells and their
function in graft-versus-host disease - review. Zhongguo Shi Yan
Xue Ye Xue Za Zhi. 14:408–412. 2006.In Chinese. PubMed/NCBI
|
|
45
|
Khazaie K and von Boehmer H: The impact of
CD4+CD25+ Treg on tumor specific
CD8+ T cell cytotoxicity and cancer. Semin Cancer Biol.
16:124–136. 2006. View Article : Google Scholar : PubMed/NCBI
|
